Skip to content

Effect of Whole-body Vibration on Insulin Resistance in Obese Postmenopausal Women.

Effect of Whole-body Vibration on Insulin Resistance in Obese Postmenopausal Women.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05961020
Enrollment
40
Registered
2023-07-27
Start date
2022-11-05
Completion date
2023-07-08
Last updated
2024-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Brief summary

This study will be conducted to investigate the Effect of whole-body vibration on insulin resistance in obese postmenopausal women

Detailed description

The prevalence of obesity has tripled over the past four decades, imposing an enormous burden on people's health. Obesity is associated with premature mortality and is a serious public health threat that accounts for a large proportion of the worldwide non-communicable disease burden, including type 2 diabetes, cardiovascular disease, hypertension, and certain cancers. reported that Whole-body vibration (WBV) training has been established as a useful method to improve physical fitness in obese individuals. Vibration stimulus during half squatting might suggest a long-term effect of WBV on the endocrine system. Therefore, in this study, The aim to investigate the effect of whole-body vibration on insulin resistance in obese postmenopausal.

Interventions

DEVICETotal body vibration

Whole-body vibration (WBV) training has been established as a useful method to improve physical fitness in obese individuals. Vibration stimulus during half squatting might suggest a long-term effect of WBV on the endocrine system

OTHERmoderate restricted diet

moderate restricted diet

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* All women were postmenopausal with no menses at least 1 year. * Their ages were ranged from 50-60 years old. * Their body mass index (BMI) \> 30 kg/m2. * They were not engaged in any other treatment program.

Exclusion criteria

* Women with body mass index (BMI) \< 30 kg/m2. * Any cardio-respiratory diseases. * Diabetes mellitus. * with malignancy. * with severe hemorrhage, acute viral disease and mental disorders. * Smokers. * Women with life threatening disorders as renal failure

Design outcomes

Primary

MeasureTime frameDescription
The Homeostatic model assessment (The HOMA-IR).up to 3 monthsThe Homeostatic model assessment (The HOMA-IR). A sample of 5ml of venous blood sample was drawn from all women after 12 hours fasting for measurement of fasting blood glucose, fasting blood insulin and then detection of insulin resistance (by HOMA -IR) through the equation: HOMA-IR=(Glucose ×Insulin)/405 glucose in mass unit (mg/dl)
BMIup to 3 monthsWeight and height were measured to detect the BMI according to the following equation: BMI= weight/height² (Kg/m²)
Waist circumferenceup to 3 monthsA non-stretchable tape measurement was used to measure waist circumference for all women in both groups A and B: mid-way between upper border of the lateral iliac crest and the lower border of the lowest rib at the end of gentle expiration with arm relaxed at sides.
Skin fold thicknessup to 3 monthsSkin fold caliper was used to measure skin fold thickness at abdominal region for all women in both groups A and B

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026